Future Consumer is currently trading at Rs. 40.60, up by 0.10 points or 0.25% from its previous closing of Rs. 40.50 on the BSE. The scrip opened at Rs. 41.50 and has touched a high and low of Rs. 41.50 and Rs. 39.90 respectively. So far 136217 shares were traded on the counter. The BSE … Read more
Steel Strips Wheels (SSWL) is expecting to achieve highest ever quarterly sales in Q3 with the help of truck and tractor segment growth. The company is expecting Sales volume of 44.65 Lakh (In Nos.) in Q3 FY 2018-19 (Oct-Dec 2018). The growth will be driven by extremely buoyant order book of tractor and truck wheel … Read more
Trident has reported results for second quarter ended September 30, 2018. The company has reported over 2 fold jump in its net profit at Rs 109.14 crore for the quarter under review as compared to Rs 50.90 crore for the same quarter in the previous year. Total income of the company increased by 21.25% at … Read more
Astron Paper & Board Mill’s PM-2 at unit-1 located at Halvad, Gujarat has commenced commercial production of kraft paper from October 15, having installed capacity of 33000 MT/year. The company is currently operating at almost 90% capacity utilization of its PM-1 located at Halvad, with installed capacity of 96,000 MT per annum. With the commencement … Read more
Dr. Reddy’s Laboratories has received an approval for Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release dipyridamole) Capsules in the United States market from the US Food and Drug Administration (USFDA). The company is working towards launching the product. The Aggrenox brand and generic had US sales of … Read more
IndusInd Bank has reported results for second quarter ended September 30, 2018. The Bank has reported 4.56% rise in its net profit at Rs 920.25 crore for the quarter under review as compared to Rs 880.10 crore for the same quarter in the previous year. Total income of the Bank increased by 25.19% at Rs … Read more
Lupin has received tentative approval for its Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Sunovion Pharmaceuticals Inc.’s (Sunovion) Latuda Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg. Lupin’s Lurasidone … Read more
